SUCLG1 and rheumatoid arthritis: Indeed, previous publications suggest that biological treatments can modulate DR [46], and chronic inflammation in RA can lead to a switch of the Galpha subunit of GPCR [25], thus possibly altering the effect of GPCR such as DR.